A CD137 agonist induced primary GC cell apoptosis by enhancing CD8+ T cells via activation of NF-κB signaling and increased the secretion of IFN-γ, perforin and granzyme B, but had little effect on Tregs in GC. The gene discussed is CD8A; the disease is gastric cancer.